Kishimoto TK, Fournier M, Michaud A, Rizzo G, et al. Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease. J Autoimmun 2023;140:103125.
PMID: 37844543